Interestingly, BCL6 overexpression extends beyond lymphomas, being implicated in breast cancer [34], ovarian cancer [[35], glioma [36], chronic myeloid leukemia [52], non-small cell lung cancer [53] and so on. This evidence concerns the gene BCL6 and breast cancer.